Back to Search
FLYNN O'MALLEY, PHD
PHD
Clinical Psychologist
NPI: 1295102234Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
31829(TX)
Research & Publications (20)
Contemporary issues in the psychiatric residential treatment of disturbed adolescents.
PMID 15062344·Child Adolesc Psychiatr Clin N Am·2004
5-case
Mentalizing in the psychotherapy of a disturbed adolescent girl.
PMID 14604100·Bull Menninger Clin·2003
5-case
Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.
PMID 19443366·Anticancer Res·2009
8-other
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.
PMID 19401546·J Natl Cancer Inst·2009
8-other
Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry.
PMID 19505912·Cancer Epidemiol Biomarkers Prev·2009
8-other
Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
PMID 19675450·Am J Surg Pathol·2009
8-other
Measuring extent of ductal carcinoma in situ in breast excision specimens: a comparison of 4 methods.
PMID 19123733·Arch Pathol Lab Med·2009
4-observational
A role for the TGFbeta-Par6 polarity pathway in breast cancer progression.
PMID 19667198·Proc Natl Acad Sci U S A·2009
7-preclinical
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.
PMID 19617568·Proc Natl Acad Sci U S A·2009
7-preclinical
Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
PMID 19123730·Arch Pathol Lab Med·2009
8-other
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/Immunohistochemistry.
PMID 19363444·Appl Immunohistochem Mol Morphol·2009
8-other
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.
PMID 19034644·Breast Cancer Res Treat·2009
4-observational
Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.
PMID 18563556·Breast Cancer Res Treat·2009
8-other
HER-2 and topoisomerase II as predictors of response to chemotherapy.
PMID 18258981·J Clin Oncol·2008
6-review
Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort.
PMID 18593996·Clin Cancer Res·2008
8-other
JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.
PMID 17990101·Breast Cancer Res Treat·2008
4-observational
HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab.
PMID 18181675·Arch Pathol Lab Med·2008
8-other
HER2/neu in systemic therapy for women with breast cancer: a systematic review.
PMID 17636396·Breast Cancer Res Treat·2008
1-meta
PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.
PMID 17721278·Appl Immunohistochem Mol Morphol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12301 MAIN ST
HOUSTON, TX 77035 - Phone
- (713) 275-5289
Quick Facts
- NPI
- 1295102234
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile